Compounds > technetium-tc-99m-medronate

technetium-tc-99m-medronate and Carcinoma--Lobular

technetium-tc-99m-medronate has been researched along with Carcinoma--Lobular* in 2 studies

Other Studies

2 other study(ies) available for technetium-tc-99m-medronate and Carcinoma--Lobular

ArticleYear
Increased renal uptake of technetium-99m HEDP in a patient with breast cancer.
    The British journal of radiology, 2010, Volume: 83, Issue:985

    Topics: Breast Neoplasms; Carcinoma, Lobular; Female; Humans; Kidney; Lymphatic Metastasis; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate; Time Factors

2010
Negative bone scintigraphy with diffuse osteoblastic breast carcinoma metastases.
    Clinical nuclear medicine, 1994, Volume: 19, Issue:3

    A patient with diffuse osteoblastic metastases from invasive lobular carcinoma of the breast is presented in whom radionuclide bone scan was negative for skeletal lesions. Skeletal metastases were documented by plain radiography, CT, MRI, and bone marrow biopsy. This case report points to the value of plain-film, CT, and MRI findings in situations of high clinical suspicion of metastatic disease despite a normal scintigraphy.

    Topics: Aged; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Carcinoma, Lobular; False Negative Reactions; Female; Humans; Magnetic Resonance Imaging; Radionuclide Imaging; Technetium Tc 99m Medronate; Tomography, X-Ray Computed

1994